首页> 美国政府科技报告 >Noninvasive Localization of Prostate Cancer via Diffusion Sensitive MRI; Annual summary rept. 15 Feb 2007-14 Feb 2008
【24h】

Noninvasive Localization of Prostate Cancer via Diffusion Sensitive MRI; Annual summary rept. 15 Feb 2007-14 Feb 2008

机译:通过扩散敏感mRI无创定位前列腺癌;年度总结报告。 2007年2月15日至2008年2月14日

获取原文

摘要

Diffusion tensor magnetic resonance imaging (DTI) measurements of prostate cancer (PCa) were performed in vivo, in patients undergoing radical prostatectomy, and ex vivo, in the same patients' prostatectomy specimens. For the first time, the imaging data were co-registered to histological sections of the prostatectomy specimens, thereby enabling unambiguous characterization of diffusion parameters in cancerous and benign tissues. Through image co- registration and histological analysis, we have shown that increased cellularity, and thence decreased luminal spaces, in peripheral zone PCa leads to about 40 % and 50 % apparent diffusion coefficient (ADC) decrease compared to benign peripheral zone tissues in vivo and ex vivo, respectively. In contrast, no significant diffusion anisotropy differences between the cancerous and non-cancerous peripheral zone tissues were observed. The bundled fibromuscular tissues in prostate, such as stromal tissues in benign prostatic hyperplasia (BPH), exhibited high diffusion anisotropy facilitating the differentiation of PCa from BPH in central gland. A tissue classification method, combining DTI and T2w images, was proposed to provide more specific PCa detection. An ADC threshold for PCa was also established to provide unsupervised PCa localization. The PCa identified using this method correlate well with histologically identified PCa foci.

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号